BBI BUERG.BRAUH.IMMO./ DE0005280002 /
| 2024-04-19 8:00:58 AM | Chg. 0.0000 | Volume | Bid8:00:59 AM | Ask8:00:59 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 7.6500EUR | 0.00% | 0 Turnover: 0.0000 |
7.6500Bid Size: 50 | 8.4000Ask Size: 50 | 43.68 mill.EUR | 8.81% | - |
GlobeNewswire
2023-11-15
Global Bioenergies strengthens its cash position thanks to several cash inflows coming from public f...
GlobeNewswire
2023-08-28
Esperion to Participate in H.C. Wainwright 25th Annual Global Investment Conference
Newsfile Corp
2022-08-24
Introducing DuraTech(TM) by Microban(R): a Non-Heavy Metal Antimicrobial Cotton Technology with Supe...
GlobeNewswire
2022-03-15
Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate ...
GlobeNewswire
2022-03-10
Brickell Biotech Selected for a Late-Breaking Oral Presentation of US Phase 3 Pivotal Cardigan I and...
GlobeNewswire
2022-03-09
New Developments on Dominica’s Geothermal Project Include International Contract, New Wells
GlobeNewswire
2022-03-08
Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corpora...
GlobeNewswire
2022-02-02
Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting A...
GlobeNewswire
2021-11-09
Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-11-01
Brickell Biotech to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on No...
GlobeNewswire
2021-10-27
Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock
GlobeNewswire
2021-10-07
Brickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Prima...
GlobeNewswire
2021-09-30
Clearcover Partners with Zendrive and Cover to Acquire Safe Drivers with Insurance Qualified Leads (...
GlobeNewswire
2021-09-17
Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and its Role in Autoimmunity
GlobeNewswire
2021-09-01
Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
GlobeNewswire
2021-09-01
Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platf...
GlobeNewswire
2021-08-16
Brickell Biotech Announces Final Patient Completed Second U.S. Phase 3 Pivotal Clinical Study of Sof...
GlobeNewswire
2021-08-12
Brickell Biotech Reports Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-07-29
Brickell Biotech to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on A...
GlobeNewswire
2021-07-22
Brickell Biotech Announces Closing of $8.05 Million Bought Deal Offering of Common Stock, Including ...
GlobeNewswire
2021-07-20
Brickell Biotech Increases Previously Announced Bought Deal Offering of Common Stock to $7.0 Million
